{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-259995","form_type":"8-K","ticker":null,"cik":"0001776197","company_name":"AKUMIN INC.","filed_at":"2023-10-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.385743+00:00","generated_at":"2026-06-09T18:46:01.660295+00:00","sec_items":["1.01","3.01","5.02","7.01","8.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"Akumin reaches RSA with Stonepeak to go private; files prepackaged Chapter 11","bullets":["Prepackaged Chapter 11 filing planned; RSA with Stonepeak to take Akumin private.","Stonepeak to invest $130M; $60M for reverse Dutch election for noteholders.","Existing common stockholders to receive $25M cash plus contingent value rights.","Nasdaq delisting due to non-compliance with bid price and equity standards.","Ransomware incident likely exposed protected health info; investigation ongoing."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-259995","json":"https://secwatch.observer/filing/0001193125-23-259995.json","markdown":"https://secwatch.observer/filing/0001193125-23-259995.md","text":"https://secwatch.observer/filing/0001193125-23-259995.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1776197/000119312523259995/0001193125-23-259995-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1776197/000119312523259995/d380424d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T18:46:01.660295+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"436574475850ec88400b040ea5c97fbee8b23319","claim":"AKUMIN INC. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2), 5550(b)(1)).","evidence_excerpt":"h will remove the Company’s securities from being listed on Nasdaq. 2 The Staff Delisting Determination is based on the Company’s continued non-compliance with (i) the minimum bid price requirement for continued inclusion on The Nasdaq Capital Market (the “Capital Market”) under Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Requirement”) and (ii) Nasdaq Listing Rule 5550(b)(1) (the “Equity Standard”), pursuant to which companies are required to maintain a minimum of $2,500,000 in stockholders’ equity for continued listing on the Capital Market, or either of the alternatives to compliance with","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1776197/000119312523259995/0001193125-23-259995-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"delisting notice"},{"label":"Deficiency","value":"minimum bid price"},{"label":"Rules","value":"5550(a)(2), 5550(b)(1)"}],"fact_type":"exchange_compliance_notice"},{"claim_id":"e909416f42ac7f0a683c4aff000d4b1fce1ec862","claim":"AKUMIN INC. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1), 5550(b)(2), 5550(b)(3)).","evidence_excerpt":"h will remove the Company’s securities from being listed on Nasdaq. 2 The Staff Delisting Determination is based on the Company’s continued non-compliance with (i) the minimum bid price requirement for continued inclusion on The Nasdaq Capital Market (the “Capital Market”) under Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Requirement”) and (ii) Nasdaq Listing Rule 5550(b)(1) (the “Equity Standard”), pursuant to which companies are required to maintain a minimum of $2,500,000 in stockholders’ equity for continued listing on the Capital Market, or either of the alternatives to compliance with","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1776197/000119312523259995/0001193125-23-259995-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"stockholders equity"},{"label":"Rules","value":"5550(b)(1), 5550(b)(2), 5550(b)(3)"}],"fact_type":"exchange_compliance_notice"},{"claim_id":"6e57aeaca0","claim":"Ronald J. Bienias was appointed as Chief Restructuring Officer at AKUMIN INC..","evidence_excerpt":"Appointment of Chief Restructuring Officer Effective October 20, 2023, the board of directors of the Company appointed Ronald J. Bienias to serve as the Company’s Chief Restructuring Officer (“CRO”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1776197/000119312523259995/0001193125-23-259995-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Restructuring Officer"}],"fact_type":"executive_change"},{"claim_id":"bc900005a31b406d6937718b0c09ae6743d651a6","claim":"AKUMIN INC. entered into Restructuring Support Agreement with Consenting Stakeholders (Stonepeak Magnet Holdings LP, Consenting 2025 Noteholders, Consenting 2028 Noteholders, Consenting RCF Lenders, Consenting Equityholders, Consenting Non-Debtor Hospital Partner Entities, Consenting Physician-Owned Entities) (effective 2023-10-20).","evidence_excerpt":"On October 20, 2023, the Company, entered into a Restructuring Support Agreement (including all exhibits thereto, collectively, the “RSA”) with (i) certain of its affiliates and subsidiaries (as set forth in the RSA, and together with Akumin, the “Company Parties”); (ii) Stonepeak (iii) certain Consenting 2025 Noteholders; (iv) certain Consenting 2028 Noteholders (together with the Consenting 2025 Noteholders, the “Consenting Noteholders”); (v) certain Consenting RCF Lenders; (vi) certain Consenting Equityholders; (vii) certain Consenting Non-Debtor Hospital Partner Entities; and (viii) certain Consenting Physician-Owned Entities (as each such term is defined in the RSA, and collectively, other than the Company Parties, the “Consenting Stakeholders”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1776197/000119312523259995/0001193125-23-259995-index.htm","confidence":0.95,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Counterparty","value":"Consenting Stakeholders (Stonepeak Magnet Holdings LP, Consenting 2025 Noteholders, Consenting 2028 Noteholders, Consenting RCF Lenders, Consenting Equityholders, Consenting Non-Debtor Hospital Partner Entities, Consenting Physician-Owned Entities)"},{"label":"Effective","value":"2023-10-20"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}